Latest News
Using a new computational method based on a causal inference framework, CINEMA-OT, the Yale team studied how individual immune cells react to combinations of cytokines, or small proteins released by cells that regulate inflammation. They discovered that certain cytokines have a synergistic effect, inducing unique gene activation programs compared to their individual effects. This cryptography of cytokine signals acts as a language, instructing immune cells.
- October 18, 2023
Madeline Mayday, BS, and Noah Yann Lee, BS, were recently awarded prestigious Ruth L. Kirschstein Predoctoral Individual National Research Service Awards (F31) from the National Institutes of Health (NIH).
- September 27, 2023
The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) have renewed a $20 million grant for the Yale Tobacco Center of Regulatory Science (TCORS). The Yale center is led by co-directors Suchitra Krishnan-Sarin, PhD, Albert E. Kent Professor of Psychiatry; and Stephanie O’Malley, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry.
- August 15, 2023
Samantha St. Clair, Clinical Technologist in the Immunohistochemistry Lab, was singled out for her work.
- July 05, 2023
The Yale Cooperative Center of Excellence in Hematology (YCCEH) has appointed John Hwa MD, PhD, as the joint director.
- June 09, 2023
A new study harnesses big data and bioinformatics to explore how the immune system can fight off the virus in some cases and fails in others.
- May 24, 2023
Mina L. Xu, MD, Named Founding Director of New Expert Consultation Practice in Pathology
- April 19, 2023
Dengue. Zika. Lyme. Yellow fever. Chikungunya virus. Malaria. These worldwide diseases, and others, are spread by the bite from an infected arthropod, a tick or mosquito. Five faculty from Yale School of Medicine (YSM) are collaborating on a project focusing on creating vaccines against infectious diseases by targeting the vector, which could be a “game changer” for global health.
- March 31, 2023
A Yale expert says as many as 90% of those taking levothyroxine for an underactive thyroid may not need it, and might be harmed, largely because seasonal thyroid variations can be overlooked during diagnosis.
- March 29, 2023Source: International Federation of Clinical Chemistry and Laboratory Medicine
The IFCC is pleased to announce the winners of the four IFCC Distinguished Awards. The IFCC Distinguished Awards are bestowed to laboratory medicine professionals to recognize their outstanding achievements, publicize their exceptional research and contributions to medicine and healthcare, and encourage the overall advancement of clinical chemistry and laboratory medicine.